Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction.i "Penumbra is a ...
Interventional Radiology
Interventional radiology uses tools like embolization devices to provide minimally invasive medical diagnosis and treatment using images.
Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...
Jan. 12, 2026 — YorLabs, Inc., a medical technology company providing next-generation intracardiac imaging solutions for ...
Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...
Aug. 13, 2025 — BioCardia, Inc., a provider of cellular and cell-derived therapeutics for treating cardiovascular and ...
June 5, 2025 – Penumbra, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ...
Jan. 28, 2025 — Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular ...
July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...
April 12, 2024 — Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular ...
January 9, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ...
On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI."Â
...
On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI."
...
June 22, 2023 — The Society of Interventional Radiology (SIR) published a new position statement offering ...
May 16, 2023 —  Royal Philips, a global leader in health technology, announced late-breaking data from the DCR4Contrast ...
January 19, 2026